Is there a difference in FDG PET findings of invasive ductal carcinoma of the breast with and without coexisting DCIS

Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 281

This Paper With 9 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JNMB-8-1_004

تاریخ نمایه سازی: 24 تیر 1399

Abstract:

Objective(s): Studies have reported that invasive ductal carcinoma (IDC) with coexisting ductal carcinoma in situ (DCIS) show lower metastatic potential and recurrence and better overall survival than pure IDC. In this study, we assessed F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) imagesof patients with newly diagnosed IDC to determine if there is any difference in PET findings in IDC-DCIS and pure IDC cases. Methods: FDG PET/CT images of patients with newly diagnosed IDC of the breast who subsequently   underwent breast surgery and had histopathology result in our records were further evaluated. Tumor grade, pathological staging, and presence of DCIS were noted from the histopathology results. Standardized uptake value (SUV) of the primary tumor (SUVmax and SULmax), other hypermetabolic foci in the breast, and   ipsilateral normal breast were measured. Presence of axillary and distant metastases was noted.   Results: Fifty seven (57) patients with IDC were included. Coexisting DCIS was present in 44 (IDC-DCIS) and not present in 13 (pure IDC) cases.  Per histopathology, the primary tumor was unifocal in 33 IDC-DCIS (75%) and 12 pure IDC (92.3%) cases, and multifocal in 11 IDC-DCIS cases (25%), and 1 pure IDC case (7.7%). FDG uptake was multifocal in 20 IDC-DCIS cases (45.5%) and 1 pure IDC case (7.7%), and unifocal in 24 IDC-DCIS (54.5%), and 12 pure IDC (92.3%) cases. There was no significant difference in patient age, size of the primary tumor, SUVmax and SULmax of the primary tumor and SUVmax of the normal breast in IDC-DCIS and pure IDC cases (p> 0.05). Pathology showed axillary metastasis in all 13 pure IDC (100%), and 27 IDC-DCIS (61.4%) cases. PET showed axillary uptake in 25 IDC-DCIS (56.8%), and 8 pure IDC (61.5%) cases, and abnormal/questionable distant uptake in 12 IDC-DCIS cases and 1 pure IDC case. Conclusion: In our preliminary findings,multifocal breast FDG uptake and multifocal tumor appear to be more common inIDC-DCIS than pure IDC. There is no significant difference in SUV and size of the primary tumor in IDC-DCIS and pure IDC cases. Axillary metastases appear to be more common in pure IDC than IDC-DCIS cases.

Authors

Ismet Sarikaya

Kuwait University, Faculty of Medicine, Department of Nuclear Medicine, Kuwait

Ali Sarikaya

Trakya University, Faculty of Medicine, Department of Nuclear Medicine, Turkey

Ahmed Albatineh

Kuwait University, Faculty of Medicine, Department of Community Medicine and Behavioral Sciences,Kuwait

Ebru Tastekin

Trakya University, Faculty of Medicine, Department of Pathology,Turkey

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Groheux D, Cochet A, Humbert O, Alberini JL, Hindié E, ...
  • Edge SB, Compton CC. The American Joint Committee on Cancer: ...
  • NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). National Comprehensive ...
  • Groheux D, Moretti J-L, Baillet G, Espie M, Giacchetti S, ...
  • Segaert I, Mottaghy F, Ceyssens S, De Wever W, Stroobants ...
  • Dieterich M, Hartwig F, Stubert J, Klöcking S, Kundt G, ...
  • Wong H, Lau S, Yau T, Cheung P, Epstein RJ. ...
  • Farabegoli F, Champeme MH, Bieche I, Santini D, Ceccarelli C, ...
  • Patla A, Rudnicka-Sosin L, Pawlega J, Stachura J. Prognostic significance ...
  • Wong H, Lau S, Leung R, Chiu J, Cheung P, ...
  • Chagpar AB, McMasters KM, Sahoo S, Edwards MJ.  Does ductal ...
  • Mylonas I, Makovitzky J, Jeschke U, Briese V, Friese K, ...
  • Papantoniou V, Sotiropoulou E, Valsamaki P,  Tsaroucha A, Sotiropoulou M, ...
  • Mechera R, Viehl CT, Oertli D. Factors predicting in-breast tumor ...
  • Hume R. Prediction of lean body mass from height and ...
  • Groheux D, Giacchetti S, Moretti J-L, Porcher R, Espié M, ...
  • Gil-Rendo A, Martínez-Regueira F, Zornoza G, García-Velloso MJ, Beorlegui C, ...
  • Yoon HJ, Kang KW, Chun IK, Cho N, Im SA, ...
  • Basu S, Chen W, Tchou J, Mavi A, Cermik T, ...
  • Avril N, Menzel M, Dose J, Schelling M, Weber W, ...
  • Fujioka T, Kubota K, Toriihara A, Machida Y, Okazawa K, ...
  • Azuma A, Tozaki M, Ito K, Fukuma E, Tanaka T, ...
  • Ruibal A, Maldonado A, Sánchez Salmón A, González-Alenda J, Barandela ...
  • Yoon HJ, Kim Y, Kim BS. Intratumoral metabolic heterogeneity predicts ...
  • Jo BH, Chun YK. Heterogeneity of invasive ductal carcinoma: proposal ...
  • Logullo AF, Godoy AB, Mourão-Neto M, Simpson AJ, Nishimoto IN, ...
  • Sarikaya I, Sarikaya A. Assessing (18) F-FDG Uptake in the ...
  • Andersson Y, Frisell J, Sylvan M, de Boniface J, Bergkvist ...
  • Rath MG, Heil J, Domschke C, Topic Z, Schneider S, ...
  • Dong A, Wang Y, Lu J, Zuo C.  Spectrum of ...
  • Lin CY, Ding HJ, Liu CS, Chen YK, Lin CC, ...
  • نمایش کامل مراجع